docetaxel,darolutamide
bayer
['nubeqa', 'prostate', 'arasens', 'gu ', 'darolutamide']
new nubeqa (darolutamide) subgroup analyses from the phase iii arasens trial in metastatic hormone-sensitive prostate cancer (mhspc) patients presented at asco gu 
Pharmaceutical News - Direct Information